Hi all,
Have a question relating to the tax treatment of spinoffs. I have a very small holding in Pfizer and they recently offered shareholders 0.124079 shares of Viatris common stock for every one share of Pfizer common stock held as of the close of business on the record date (which was November 13, 2020). Shareholding in Pfizer remained unchanged after the spin-off. As my shareholding was small enough so that the offering of Viatris stock came in under 1 share, Degiro just credited my account with the equivalent value of my expected shareholding.
How is this treated for capital gains tax purposes. My thoughts would be that you are subject to cgt on the full credited figure as there is no cost of purchase or expenses to offset. Would that be correct?
My gains were less than my allowance for the tax year so no payment is due but I will need to report on it so I'm curious.
Cheers, G.